Literature DB >> 14684446

Short- and long-term modulation of synaptic inputs to brain reward areas by nicotine.

Zara M Fagen1, Huibert D Mansvelder, J Russel Keath, Daniel S McGehee.   

Abstract

Dopamine signaling in brain reward areas is a key element in the development of drug abuse and dependence. Recent anatomical and electrophysiological research has begun to elucidate both complexity and specificity in synaptic connections between ventral tegmental neurons and their inputs. Specifically, the activity of dopamine neurons in the ventral tegmental area relies on the combination of both excitatory and inhibitory inputs. Controlling endogenous neurotransmission to dopamine neurons is one mechanism by which drugs of abuse affect both transient and long-term changes in synaptic activity. Here, we review recent findings concerning glutamatergic, GABAergic, and cholinergic inputs to dopamine neurons, and their roles in the reinforcement associated with drug abuse. Importantly, several studies support that a single drug exposure can lead to changes in synaptic strength that are associated with learning and memory. Ultimately, these cellular changes could underlie the long-lasting effects of drugs. Furthermore, nicotinic acetylcholine receptors in the ventral tegmental area emerge as a possible common target for the behavioral and cellular actions not only of nicotine, but also of several other drugs of abuse. Finally, we explore age-related differences in nicotine sensitivity in order to understand both human epidemiological data, and laboratory animal behavioral findings that suggest adolescents are more susceptible to developing nicotine dependence.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14684446     DOI: 10.1196/annals.1300.011

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  24 in total

Review 1.  Nicotinic modulation of neuronal networks: from receptors to cognition.

Authors:  Huibert D Mansvelder; Karlijn I van Aerde; Jonathan J Couey; Arjen B Brussaard
Journal:  Psychopharmacology (Berl)       Date:  2005-07-02       Impact factor: 4.530

2.  Vulnerability to smoking after trying a single cigarette can lie dormant for three years or more.

Authors:  J A Fidler; J Wardle; N Henning Brodersen; M J Jarvis; R West
Journal:  Tob Control       Date:  2006-06       Impact factor: 7.552

Review 3.  Nicotinic receptors containing the alpha7 subunit: a model for rational drug design.

Authors:  G Sharma; S Vijayaraghavan
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

4.  Activation of α7 nicotinic acetylcholine receptors increases intracellular cAMP levels via activation of AC1 in hippocampal neurons.

Authors:  Qing Cheng; Jerrel L Yakel
Journal:  Neuropharmacology       Date:  2015-04-29       Impact factor: 5.250

Review 5.  Biological mechanisms underlying the relationship between stress and smoking: state of the science and directions for future work.

Authors:  Jessica M Richards; Brooke A Stipelman; Marina A Bornovalova; Stacey B Daughters; Rajita Sinha; C W Lejuez
Journal:  Biol Psychol       Date:  2011-07-07       Impact factor: 3.251

6.  The Gateway Effect of E-cigarettes: Reflections on Main Criticisms.

Authors:  Simon Chapman; David Bareham; Wasim Maziak
Journal:  Nicotine Tob Res       Date:  2019-04-17       Impact factor: 4.244

Review 7.  Glial-neuronal interactions--implications for plasticity and drug addiction.

Authors:  Sukumar Vijayaraghavan
Journal:  AAPS J       Date:  2009-02-24       Impact factor: 4.009

8.  Nicotinic Receptors: Role in Addiction and Other Disorders of the Brain.

Authors:  Geeta Sharma; Sukumar Vijayaraghavan
Journal:  Subst Abuse       Date:  2008-11-11

Review 9.  Acetylcholine as a neuromodulator: cholinergic signaling shapes nervous system function and behavior.

Authors:  Marina R Picciotto; Michael J Higley; Yann S Mineur
Journal:  Neuron       Date:  2012-10-04       Impact factor: 17.173

Review 10.  The effect of α7 nicotinic receptor activation on glutamatergic transmission in the hippocampus.

Authors:  Qing Cheng; Jerrel L Yakel
Journal:  Biochem Pharmacol       Date:  2015-07-23       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.